For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231212:nRSL4047Wa&default-theme=true
RNS Number : 4047W Chapel Down Group PLC 12 December 2023
Chapel Down Group plc
("Chapel Down" or the "Company" or the "Group")
EPIC: CDGP
Director Shareholdings
Chapel Down, England's leading and largest winemaker, confirms the
beneficial shareholdings of its directors following the admission of ordinary
shares to trading on AIM on 8 December 2023:
Director Position No. of ordinary shares held Percentage of current issued share capital
Martin Glenn Non-Executive Chair 283,472 0.17%
Andrew Carter Chief Executive Officer 319,669 0.19%
Robert Smith Chief Financial Officer 2,000,000 1.17%
Michael Spencer Non-Executive Director 45,823,821(1) 26.74%
Nigel Wray Non-Executive Director 23,631,970(2) 13.79%
Samantha Wren Non-Executive Director 135,552 0.09%
James Brooke Non-Executive Director 493,806 0.29%
Stewart Gilliland Non-Executive Director 390,891 0.23%
Note 1: Includes 45,645,250 ordinary shares held by IPGL Limited of which
Michael Spencer is the beneficial owner.
Note 2: Includes 21,195,571 Ordinary Shares are held by family trusts whose
beneficiaries are Nigel Wray's children.
Contacts
Chapel Down Group plc Chief Executive
Andrew Carter Chief Financial Officer 01580 763 033
Rob Smith
Nominated Adviser and Broker
Singer Capital Markets
Shaun Dobson 020 7496 3000
Tom Salvesen
Asha Chotai
James Fischer
H/Advisors Maitland
Sam Cartwright 020 73795151
Jonathan Cook
About Chapel Down
Chapel Down is England's leading wine producer with an award-winning range
of sparkling and still wines. Based in Kent, in the heart of the Garden
of England, Chapel Down produces wines of the highest quality and which the
winemaker believes offer the best expression of England.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFFEFUFEDSESE